StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.66−0.03 (-4.76%)

Close on Nov 17, 2026Market cap $40.88MP/E –Yield 0.00%

Pliant Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pliant Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0, down 100.0% year over year. For fiscal 2025 it was $0. The highest annual figure on record is $57.05M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$1.58M-83.7%
FY2022Dec 31, 2022$9.69M+27.9%
FY2021Dec 31, 2021$7.57M-81.9%
FY2020Dec 31, 2020$41.82M-26.7%
FY2019Dec 31, 2019$57.05M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$248.00K-95.0%
Q1 FY2023Mar 31, 2023$1.33M+6.6%
Q4 FY2022Dec 31, 2022$1.97M-1.7%
Q3 FY2022Sep 30, 2022$1.48M-8.0%
Q2 FY2022Jun 30, 2022$4.99M+178.9%
Q1 FY2022Mar 31, 2022$1.25M-42.5%
Q4 FY2021Dec 31, 2021$2.00M-55.2%
Q3 FY2021Sep 30, 2021$1.61M-66.6%
Q2 FY2021Jun 30, 2021$1.79M-50.3%
Q1 FY2021Mar 31, 2021$2.17M-92.5%
Q4 FY2020Dec 31, 2020$4.47M–
Q3 FY2020Sep 30, 2020$4.81M–
Q2 FY2020Jun 30, 2020$3.60M–
Q1 FY2020Mar 31, 2020$28.94M–

More Pliant Therapeutics figures

See a number that looks wrong?